πŸ‡ΊπŸ‡Έ FDA
Patent

US 7445890

Ucp-2 promoter and use thereof

granted A61KA61K38/00

Quick answer

US patent 7445890 (Ucp-2 promoter and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Oct 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Nov 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K38/00